60¢sixtycents

Harmony Biosciences Holdings, Inc.HRMY

$33.28-0.49 (-1.45%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$2B
Small-cap
-20%
2020 — today
10-Year Price
-14%
2020 — today
52-Week Range
$25.90$40.51
Current $33.28· 51%

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.

Valuation in context

P/E ratio
13.4
Around average
Around the 10-year average
P/B ratio
2.1
Near historic low
Near historic low — last 10 years
EV / EBITDA
6.7
Historically cheap
Historically cheap relative to the last 10 years
FCF Yield
17.5%
Near historic high
Near historic highs — last 10 years
Free · No credit card needed

Get alerted when HRMY is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.